Fig. 1: Patient disposition.

Two patients in the licogliflozin 150 mg treatment group were excluded from the PD analysis set: one patient was excluded due to <80% compliance in study treatment administration, and the second patient because study treatment was administered in the evening, instead of at lunchtime, throughout the study. BL, baseline; n, number of patients in each treatment group; PD, pharmacodynamics; PK, pharmacokinetic; SAF, safety analysis set.